These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8269281

  • 21. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T, Kondo S.
    J Surg Res; 2008 May 01; 146(1):32-42. PubMed ID: 17543340
    [Abstract] [Full Text] [Related]

  • 22. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T, Masson R, Basset P, Blasi F, Talarico D.
    Dev Dyn; 1999 Mar 01; 214(3):248-58. PubMed ID: 10090151
    [Abstract] [Full Text] [Related]

  • 23. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
    Wan Y, Wei Q, Pan Y, Liu Y.
    Zhonghua Wai Ke Za Zhi; 2000 Jul 01; 38(7):510-3. PubMed ID: 11832095
    [Abstract] [Full Text] [Related]

  • 24. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.
    Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148
    [Abstract] [Full Text] [Related]

  • 25. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
    Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, Kobayashi M.
    Jpn J Clin Oncol; 1996 Oct 15; 26(5):303-9. PubMed ID: 8895669
    [Abstract] [Full Text] [Related]

  • 26. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y.
    J Pathol; 2004 Apr 15; 202(4):403-11. PubMed ID: 15095267
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.
    Kikuchi R, Noguchi T, Takeno S, Kubo N, Uchida Y.
    Br J Cancer; 2000 Jul 15; 83(2):215-8. PubMed ID: 10901373
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX, Wang YL, Qin L, Xiao ZJ, Herva R, Piao YS.
    Reproduction; 2005 Jan 15; 129(1):103-13. PubMed ID: 15615902
    [Abstract] [Full Text] [Related]

  • 30. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer.
    Kahlert C, Bandapalli OR, Schirmacher P, Weitz J, Brand K.
    Anticancer Res; 2008 Jan 15; 28(3A):1459-65. PubMed ID: 18630499
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
    Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A.
    Invest Ophthalmol Vis Sci; 1998 Oct 15; 39(11):2194-200. PubMed ID: 9761302
    [Abstract] [Full Text] [Related]

  • 35. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS, Chen MZ, Wang HJ, Ke CL, Yan C, Zheng H, Hong YS.
    Ai Zheng; 2002 Oct 15; 21(10):1124-8. PubMed ID: 12508658
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA, Bergin FG, Leaper DJ.
    Br J Surg; 2000 Sep 15; 87(9):1215-21. PubMed ID: 10971431
    [Abstract] [Full Text] [Related]

  • 38. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
    McKenna GJ, Meneghetti A, Chen YL, Mui AL, Ong C, Scudamore CH, McMaster WR, Owen DA, Chung SW.
    J Surg Oncol; 2005 Jun 15; 90(4):239-46. PubMed ID: 15906368
    [Abstract] [Full Text] [Related]

  • 39. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V, Kristiansen GO, Johannsen M, Loening SA, Schnorr D, Jung K, Staack A.
    Oncol Rep; 2006 May 15; 15(5):1379-84. PubMed ID: 16596214
    [Abstract] [Full Text] [Related]

  • 40. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY, Wu YQ, Fan SQ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 15; 28(3):212-6. PubMed ID: 14653069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.